Cargando…

A breast prosthesis infection update: Two-year incidence, risk factors and management at single institution

BACKGROUND: Infection following augmentation and prosthetic-based breast reconstruction can cause significant physical and psychological distress for patients. It may delay adjuvant therapies and compromise aesthetic outcomes. The aim of this study is to identify modifiable risk factors for infectio...

Descripción completa

Detalles Bibliográficos
Autores principales: Boustany, Ashley Nadia, Elmaraghi, Shady, Agochukwu, Nneamaka, Cloyd, Benjamin, Dugan, Adam J., Rinker, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992944/
https://www.ncbi.nlm.nih.gov/pubmed/29928074
http://dx.doi.org/10.4103/ijps.IJPS_215_17
_version_ 1783330137535676416
author Boustany, Ashley Nadia
Elmaraghi, Shady
Agochukwu, Nneamaka
Cloyd, Benjamin
Dugan, Adam J.
Rinker, Brian
author_facet Boustany, Ashley Nadia
Elmaraghi, Shady
Agochukwu, Nneamaka
Cloyd, Benjamin
Dugan, Adam J.
Rinker, Brian
author_sort Boustany, Ashley Nadia
collection PubMed
description BACKGROUND: Infection following augmentation and prosthetic-based breast reconstruction can cause significant physical and psychological distress for patients. It may delay adjuvant therapies and compromise aesthetic outcomes. The aim of this study is to identify modifiable risk factors for infection and identify common bacterial isolates to achieve optimal outcomes for patients. METHODS: A retrospective cohort study was performed for patients undergoing implant-based breast reconstruction over a 2-year period. In each case, we documented demographics, co-morbidities, complications and antibiotic use. We reviewed treatments, infectious species cultured where applicable and all outcomes. RESULTS: A total of 292 patients met the inclusion criteria. Fifty-five patients (19%) developed an infection. Univariate analysis showed a significantly increased infection rate with longer operative times (P = 0.001) and use of tissue expanders (P = 0.001). Multiple logistic regression analysis confirmed drain use and elevated body mass index (BMI) as risk factors (odds ratio [OR] 2.427 and 1.061, respectively). After controlling for BMI, smoking status and radiation, we found an increased odd of infection with allograft use (OR 1.838) and a decreased odd with skin preparation using 2% chlorhexidine gluconate in 70% isopropyl (OR 0.554), though not statistically significant. Forty of 55 patients with infections had cultures, with 62.5% of isolates being Gram-positive species and 30% Gram-negative species. The median time to clinical infection was 25 days. Implant salvage with surgical interventions was achieved in 61.5% of patients. CONCLUSIONS: This study identified judicious use of drains and efficiency in the operating room as modifiable risk factors for infections following implant-based breast reconstruction. Prospective trials to analyse techniques for infection prevention are warranted. Implant salvage following infection is a possible end-point in the appropriate patient.
format Online
Article
Text
id pubmed-5992944
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-59929442018-06-20 A breast prosthesis infection update: Two-year incidence, risk factors and management at single institution Boustany, Ashley Nadia Elmaraghi, Shady Agochukwu, Nneamaka Cloyd, Benjamin Dugan, Adam J. Rinker, Brian Indian J Plast Surg Original Article BACKGROUND: Infection following augmentation and prosthetic-based breast reconstruction can cause significant physical and psychological distress for patients. It may delay adjuvant therapies and compromise aesthetic outcomes. The aim of this study is to identify modifiable risk factors for infection and identify common bacterial isolates to achieve optimal outcomes for patients. METHODS: A retrospective cohort study was performed for patients undergoing implant-based breast reconstruction over a 2-year period. In each case, we documented demographics, co-morbidities, complications and antibiotic use. We reviewed treatments, infectious species cultured where applicable and all outcomes. RESULTS: A total of 292 patients met the inclusion criteria. Fifty-five patients (19%) developed an infection. Univariate analysis showed a significantly increased infection rate with longer operative times (P = 0.001) and use of tissue expanders (P = 0.001). Multiple logistic regression analysis confirmed drain use and elevated body mass index (BMI) as risk factors (odds ratio [OR] 2.427 and 1.061, respectively). After controlling for BMI, smoking status and radiation, we found an increased odd of infection with allograft use (OR 1.838) and a decreased odd with skin preparation using 2% chlorhexidine gluconate in 70% isopropyl (OR 0.554), though not statistically significant. Forty of 55 patients with infections had cultures, with 62.5% of isolates being Gram-positive species and 30% Gram-negative species. The median time to clinical infection was 25 days. Implant salvage with surgical interventions was achieved in 61.5% of patients. CONCLUSIONS: This study identified judicious use of drains and efficiency in the operating room as modifiable risk factors for infections following implant-based breast reconstruction. Prospective trials to analyse techniques for infection prevention are warranted. Implant salvage following infection is a possible end-point in the appropriate patient. Medknow Publications & Media Pvt Ltd 2018 /pmc/articles/PMC5992944/ /pubmed/29928074 http://dx.doi.org/10.4103/ijps.IJPS_215_17 Text en Copyright: © 2018 Indian Journal of Plastic Surgery http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Boustany, Ashley Nadia
Elmaraghi, Shady
Agochukwu, Nneamaka
Cloyd, Benjamin
Dugan, Adam J.
Rinker, Brian
A breast prosthesis infection update: Two-year incidence, risk factors and management at single institution
title A breast prosthesis infection update: Two-year incidence, risk factors and management at single institution
title_full A breast prosthesis infection update: Two-year incidence, risk factors and management at single institution
title_fullStr A breast prosthesis infection update: Two-year incidence, risk factors and management at single institution
title_full_unstemmed A breast prosthesis infection update: Two-year incidence, risk factors and management at single institution
title_short A breast prosthesis infection update: Two-year incidence, risk factors and management at single institution
title_sort breast prosthesis infection update: two-year incidence, risk factors and management at single institution
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992944/
https://www.ncbi.nlm.nih.gov/pubmed/29928074
http://dx.doi.org/10.4103/ijps.IJPS_215_17
work_keys_str_mv AT boustanyashleynadia abreastprosthesisinfectionupdatetwoyearincidenceriskfactorsandmanagementatsingleinstitution
AT elmaraghishady abreastprosthesisinfectionupdatetwoyearincidenceriskfactorsandmanagementatsingleinstitution
AT agochukwunneamaka abreastprosthesisinfectionupdatetwoyearincidenceriskfactorsandmanagementatsingleinstitution
AT cloydbenjamin abreastprosthesisinfectionupdatetwoyearincidenceriskfactorsandmanagementatsingleinstitution
AT duganadamj abreastprosthesisinfectionupdatetwoyearincidenceriskfactorsandmanagementatsingleinstitution
AT rinkerbrian abreastprosthesisinfectionupdatetwoyearincidenceriskfactorsandmanagementatsingleinstitution
AT boustanyashleynadia breastprosthesisinfectionupdatetwoyearincidenceriskfactorsandmanagementatsingleinstitution
AT elmaraghishady breastprosthesisinfectionupdatetwoyearincidenceriskfactorsandmanagementatsingleinstitution
AT agochukwunneamaka breastprosthesisinfectionupdatetwoyearincidenceriskfactorsandmanagementatsingleinstitution
AT cloydbenjamin breastprosthesisinfectionupdatetwoyearincidenceriskfactorsandmanagementatsingleinstitution
AT duganadamj breastprosthesisinfectionupdatetwoyearincidenceriskfactorsandmanagementatsingleinstitution
AT rinkerbrian breastprosthesisinfectionupdatetwoyearincidenceriskfactorsandmanagementatsingleinstitution